ACS DOBFAR SPA RX
FDA Approved Drugs

ACS DOBFAR SPA RX

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX
  • Total Records 31
  • Latest Approval Date Oct 26, 2018
  • Data Source FDA
  • First Approval Date Nov 20, 1985
All
63
View
Discontinued
32
View
RX
31
View
Company Overview

Company

ACS DOBFAR SPA RX

Country

Italy

Social Profiles

Company Snapshot

ACS DOBFAR SPA RX

Viale Addetta 4/12 20067 Tribiano (Milan)

Italy

www.acsdobfar.it/ info@acsdobfar.it View on Map
FDA Approved Drug Records ( 31 records )
2009
23 Dec
RX Application: 65403

Drug Name

AMPICILLIN AND SULBACTAM

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL

Approval Date

2009-12-23

65403 / 1

Active Ingredient

AMPICILLIN SODIUM; SULBACTAM SODIUM

Application Number

65403

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL

Approval Date

2009-12-23

Regulatory Status

RX

2009
22 Dec
RX Application: 65406

Drug Name

AMPICILLIN AND SULBACTAM

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL

Approval Date

2009-12-22

65406 / 1

Active Ingredient

AMPICILLIN SODIUM; SULBACTAM SODIUM

Application Number

65406

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL;EQ 500MG BASE/VIAL

Approval Date

2009-12-22

Regulatory Status

RX

2009
22 Dec
RX Application: 65406

Drug Name

AMPICILLIN AND SULBACTAM

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL

Approval Date

2009-12-22

65406 / 2

Active Ingredient

AMPICILLIN SODIUM; SULBACTAM SODIUM

Application Number

65406

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL;EQ 1GM BASE/VIAL

Approval Date

2009-12-22

Regulatory Status

RX

2013
03 Apr
RX Application: 90889

Drug Name

AMPICILLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2013-04-03

90889 / 1

Active Ingredient

AMPICILLIN SODIUM

Application Number

90889

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2013-04-03

Regulatory Status

RX

2008
22 Oct
RX Application: 65303

Drug Name

CEFAZOLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2008-10-22

65303 / 1

Active Ingredient

CEFAZOLIN SODIUM

Application Number

65303

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2008-10-22

Regulatory Status

RX

2008
22 Oct
RX Application: 65303

Drug Name

CEFAZOLIN SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2008-10-22

65303 / 2

Active Ingredient

CEFAZOLIN SODIUM

Application Number

65303

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2008-10-22

Regulatory Status

RX

2008
22 Oct
RX Application: 65306

Drug Name

CEFAZOLIN SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2008-10-22

65306 / 1

Active Ingredient

CEFAZOLIN SODIUM

Application Number

65306

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2008-10-22

Regulatory Status

RX

2014
18 Aug
RX Application: 65306

Drug Name

CEFAZOLIN SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 20GM BASE/VIAL

Approval Date

2014-08-18

65306 / 2

Active Ingredient

CEFAZOLIN SODIUM

Application Number

65306

Product Number

2

Dosage Form

-

Strength

EQ 20GM BASE/VIAL

Approval Date

2014-08-18

Regulatory Status

RX

2008
20 Mar
RX Application: 65441

Drug Name

CEFEPIME HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2008-03-20

65441 / 1

Active Ingredient

CEFEPIME HYDROCHLORIDE

Application Number

65441

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2008-03-20

Regulatory Status

RX

2008
20 Mar
RX Application: 65441

Drug Name

CEFEPIME HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2008-03-20

65441 / 2

Active Ingredient

CEFEPIME HYDROCHLORIDE

Application Number

65441

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2008-03-20

Regulatory Status

RX

2009
12 Jun
RX Application: 65414

Drug Name

CEFOXITIN

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2009-06-12

65414 / 1

Active Ingredient

CEFOXITIN SODIUM

Application Number

65414

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2009-06-12

Regulatory Status

RX

2009
12 Jun
RX Application: 65414

Drug Name

CEFOXITIN

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2009-06-12

65414 / 2

Active Ingredient

CEFOXITIN SODIUM

Application Number

65414

Product Number

2

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2009-06-12

Regulatory Status

RX

2010
19 May
RX Application: 65415

Drug Name

CEFOXITIN

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2010-05-19

65415 / 1

Active Ingredient

CEFOXITIN SODIUM

Application Number

65415

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2010-05-19

Regulatory Status

RX

1985
20 Nov
RX Application: 62640

Drug Name

CEFTAZIDIME

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

1985-11-20

62640 / 2

Active Ingredient

CEFTAZIDIME

Application Number

62640

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

1985-11-20

Regulatory Status

RX

1985
20 Nov
RX Application: 62640

Drug Name

CEFTAZIDIME

Product Number

3

Dosage Form

-

Strength

2GM/VIAL

Approval Date

1985-11-20

62640 / 3

Active Ingredient

CEFTAZIDIME

Application Number

62640

Product Number

3

Dosage Form

-

Strength

2GM/VIAL

Approval Date

1985-11-20

Regulatory Status

RX

1992
03 Feb
RX Application: 62640

Drug Name

CEFTAZIDIME

Product Number

4

Dosage Form

-

Strength

6GM/VIAL

Approval Date

1992-02-03

62640 / 4

Active Ingredient

CEFTAZIDIME

Application Number

62640

Product Number

4

Dosage Form

-

Strength

6GM/VIAL

Approval Date

1992-02-03

Regulatory Status

RX

2008
24 Jul
RX Application: 65328

Drug Name

CEFTRIAXONE

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2008-07-24

65328 / 1

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65328

Product Number

1

Dosage Form

-

Strength

EQ 10GM BASE/VIAL

Approval Date

2008-07-24

Regulatory Status

RX

2008
24 Jul
RX Application: 65329

Drug Name

CEFTRIAXONE

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2008-07-24

65329 / 1

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65329

Product Number

1

Dosage Form

-

Strength

EQ 500MG BASE/VIAL

Approval Date

2008-07-24

Regulatory Status

RX

2008
24 Jul
RX Application: 65329

Drug Name

CEFTRIAXONE

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2008-07-24

65329 / 2

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65329

Product Number

2

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2008-07-24

Regulatory Status

RX

2008
24 Jul
RX Application: 65329

Drug Name

CEFTRIAXONE

Product Number

3

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2008-07-24

65329 / 3

Active Ingredient

CEFTRIAXONE SODIUM

Application Number

65329

Product Number

3

Dosage Form

-

Strength

EQ 2GM BASE/VIAL

Approval Date

2008-07-24

Regulatory Status

RX

1997
30 May
RX Application: 64125

Drug Name

CEFUROXIME SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 750MG BASE/VIAL

Approval Date

1997-05-30

64125 / 1

Active Ingredient

CEFUROXIME SODIUM

Application Number

64125

Product Number

1

Dosage Form

-

Strength

EQ 750MG BASE/VIAL

Approval Date

1997-05-30

Regulatory Status

RX

1997
30 May
RX Application: 64125

Drug Name

CEFUROXIME SODIUM

Product Number

2

Dosage Form

-

Strength

EQ 1.5GM BASE/VIAL

Approval Date

1997-05-30

64125 / 2

Active Ingredient

CEFUROXIME SODIUM

Application Number

64125

Product Number

2

Dosage Form

-

Strength

EQ 1.5GM BASE/VIAL

Approval Date

1997-05-30

Regulatory Status

RX

2018
16 Apr
RX Application: 208790

Drug Name

ERTAPENEM SODIUM

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2018-04-16

208790 / 1

Active Ingredient

ERTAPENEM SODIUM

Application Number

208790

Product Number

1

Dosage Form

-

Strength

EQ 1GM BASE/VIAL

Approval Date

2018-04-16

Regulatory Status

RX

2011
21 Dec
RX Application: 90577

Drug Name

IMIPENEM AND CILASTATIN

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL;250MG/VIAL

Approval Date

2011-12-21

90577 / 1

Active Ingredient

CILASTATIN SODIUM; IMIPENEM

Application Number

90577

Product Number

1

Dosage Form

-

Strength

EQ 250MG BASE/VIAL;250MG/VIAL

Approval Date

2011-12-21

Regulatory Status

RX

2011
21 Dec
RX Application: 90577

Drug Name

IMIPENEM AND CILASTATIN

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL;500MG/VIAL

Approval Date

2011-12-21

90577 / 2

Active Ingredient

CILASTATIN SODIUM; IMIPENEM

Application Number

90577

Product Number

2

Dosage Form

-

Strength

EQ 500MG BASE/VIAL;500MG/VIAL

Approval Date

2011-12-21

Regulatory Status

RX

2011
26 Oct
RX Application: 91404

Drug Name

MEROPENEM

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2011-10-26

91404 / 1

Active Ingredient

MEROPENEM

Application Number

91404

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2011-10-26

Regulatory Status

RX

2011
26 Oct
RX Application: 91404

Drug Name

MEROPENEM

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

2011-10-26

91404 / 2

Active Ingredient

MEROPENEM

Application Number

91404

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

2011-10-26

Regulatory Status

RX

2016
09 Jun
RX Application: 204139

Drug Name

MEROPENEM

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2016-06-09

204139 / 1

Active Ingredient

MEROPENEM

Application Number

204139

Product Number

1

Dosage Form

-

Strength

500MG/VIAL

Approval Date

2016-06-09

Regulatory Status

RX

2016
09 Jun
RX Application: 204139

Drug Name

MEROPENEM

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

2016-06-09

204139 / 2

Active Ingredient

MEROPENEM

Application Number

204139

Product Number

2

Dosage Form

-

Strength

1GM/VIAL

Approval Date

2016-06-09

Regulatory Status

RX

2018
26 Oct
RX Application: 205043

Drug Name

PENICILLIN G POTASSIUM

Product Number

1

Dosage Form

-

Strength

5,000,000 UNITS/VIAL

Approval Date

2018-10-26

205043 / 1

Active Ingredient

PENICILLIN G POTASSIUM

Application Number

205043

Product Number

1

Dosage Form

-

Strength

5,000,000 UNITS/VIAL

Approval Date

2018-10-26

Regulatory Status

RX

2018
26 Oct
RX Application: 205043

Drug Name

PENICILLIN G POTASSIUM

Product Number

2

Dosage Form

-

Strength

20,000,000 UNITS/VIAL

Approval Date

2018-10-26

205043 / 2

Active Ingredient

PENICILLIN G POTASSIUM

Application Number

205043

Product Number

2

Dosage Form

-

Strength

20,000,000 UNITS/VIAL

Approval Date

2018-10-26

Regulatory Status

RX

Related Databases
  • FDA Inspections
    17 View
  • EDQM CEP
    20 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    11 View
  • FDA Approved Drugs Database
    63 View
Drug Status Breakdown
31 total
  • RX
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

AMPICILLIN AND SULBACTAM

Application Number

65403

Product Number

1

Active Ingredient

AMPICILLIN SODIUM; SULBACTAM SODIUM

Dosage Form

-

Strength

EQ 10GM BASE/VIAL;EQ 5GM BASE/VIAL

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.